Poly(lactic-co-glycolic acid) electrospun fibrous meshes for the controlled release of retinoic acid
Source abstract
Abstract
Poly(lactic-co-glycolic acid) (PLGA) meshes loaded with retinoic acid (RA) were prepared by applying the electrospinning technique. The purpose of the present work was to combine the biological effects of RA and the advantages of electrospun meshes to enhancing the mass transfer features of controlled release systems and cell interaction with polymeric scaffolds. The processing conditions for the fabrication of three-dimensional meshes were optimized by studying their influence on mesh morphology. Tensile testing showed that RA loading influenced the meshes' mechanical properties by increasing their strength and rigidity. Moreover, the drug release and degradation profiles of the electrospun systems were compared to analogous RA-loaded PLGA films prepared by solvent casting. The results of this study highlight that the electrospun meshes preserved their fibrous structure after 4 months under in vitro physiological conditions and showed a sustained controlled release of the loaded agent in comparison to that observed for cast films. The bioactivity of the loaded RA was investigated on murine preosteoblasts cells by evaluating its influence on cell proliferation and morphology.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · biodegradable polymer synthesis and properties · Polymer Surface Interaction Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (90)
Show source-provided references
1. Synthetic nano-scale fibrous extracellular matrix10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H ↗
2. Fabrication of nano-structured porous PLLA scaffold intended for nerve tissue engineering10.1016/j.biomaterials.2003.08.062 ↗
3. Membrane-based synthesis of nanomaterials10.1021/cm960166s ↗
4. Feng · Angew. Chem. Int. Ed. · 2002 · 41 · 122110.1002/1521-3773(20020402)41:7<1221::AID-ANIE1221>3.0.CO;2-G ↗
5. Polystyrene-block-poly(2-cinnamoylethyl methacrylate) nanofibers – preparation, characterization, and liquid crystalline properties10.1002/(SICI)1521-3765(19990903)5:9<2740::AID-CHEM2740>3.0.CO;2-V ↗
6. Self-assembly at all scales10.1126/science.1070821 ↗
7. Recent development of polymer nanofibers for biomedical and biotechnological applications10.1007/s10856-005-4428-x ↗
8. Electrospinning of polymeric nanofibers for tissue engineering applications: a review10.1089/ten.2006.12.1197 ↗
9. Electrospinning of polymeric and ceramic nanofibers as uniaxially aligned arrays10.1021/nl0344256 ↗
10. Novel biodegradable electrospun membrane: scaffold for tissue engineering10.1016/j.biomaterials.2003.09.043 ↗
11. In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold10.1089/107632704322791673 ↗
12. Effect of fiber diameter on spreading, proliferation, and differentiation of osteoblastic cells on electrospun poly(lactic acid) substrates10.1016/j.biomaterials.2005.05.084 ↗
13. Guided bone regeneration membrane made of polycaprolactone/calcium carbonate composite nano-fibers10.1016/j.biomaterials.2004.09.014 ↗
14. Controlled fabrication of a biological vascular substitute10.1016/j.biomaterials.2005.07.048 ↗
15. Double-walled microspheres for the sustained release of a highly water soluble drug: characterization and irradiation studies10.1016/S0168-3659(02)00235-3 ↗
16. Characterization of the initial burst release of a model peptide from poly(dl-lactide-co-glycolide) microspheres10.1016/S0168-3659(02)00137-2 ↗
17. Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices10.1016/S0142-9612(01)00291-5 ↗
18. Biodegradable microparticles for the mucosal delivery of antibacterial and dietary antigens10.1016/S0378-5173(02)00181-3 ↗
19. Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity10.1016/S0168-3659(02)00212-2 ↗
20. Residual polyvinyl alcohol associated with poly(dl-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake10.1016/S0168-3659(02)00127-X ↗
21. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamin E TPGS10.1016/S0168-3659(02)00320-6 ↗
22. PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines10.1016/j.addr.2004.09.007 ↗
23. Effect of acidic pH on PLGA microsphere degradation and release10.1016/j.jconrel.2007.05.034 ↗
24. Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymers10.1016/S0168-3659(03)00097-X ↗
25. Electrospun poly(l-lactide-co-glycolide) biodegradable polymer nanofibre tubes for peripheral nerve regeneration10.1088/0957-4484/15/11/014 ↗
26. Electrospun fine-textured scaffolds for heart tissue constructs10.1016/j.biomaterials.2005.01.052 ↗
27. Poly(l-lactide-co-glycolide) biodegradable microfibers and electrospun nanofibers for nerve tissue engineering: an in vitro study10.1007/s10853-006-0714-3 ↗
28. Hybrid nanofibrous membranes of PLGA/chitosan fabricated via an electrospinning array10.1002/jbm.a.31408 ↗
29. The biodegradability of electrospun dextran/PLGA scaffold in a fibroblast/macrophage co-culture10.1016/j.biomaterials.2007.12.005 ↗
30. Effect of solution properties on nanofibrous structure of electrospun poly(lactic-co-glycolic acid)10.1002/app.22602 ↗
31. Retinoids in development
32. Retinoic acid induced death of ovarian carcinoma cells correlates with c-myc stimulation10.1002/ijc.2910610511 ↗
33. All-trans-retinoic acid alters myc gene expression and inhibits in vitro progression in small cell lung cancer
34. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia10.1182/blood.V72.2.567.567 ↗
35. All-TRANS, 13-CIS and 9-CIS retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: implications for in vivo retinoic acid use10.1002/(SICI)1097-0215(19970117)70:2<194::AID-IJC10>3.0.CO;2-J ↗
36. Differentiation of radial glia-like cells from embryonic stem cells10.1002/glia.10202 ↗
37. Derivation of motor neurons from three clonal human embryonic stem cell lines10.2174/156720206778792902 ↗
38. Human embryonic stem cell differentiation on tissue engineering scaffolds: effects of NGF and retinoic acid induction10.1089/ten.tea.2007.0213 ↗
39. Modulation of expression and cell surface binding of members of the transforming growth factor-beta superfamily during retinoic acid-induced osteoblastic differentiation of multipotential mesenchymal cells
40. Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures10.1002/jcp.1041460306 ↗
41. Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells10.1089/107632700300003323 ↗
42. Thyroid hormone, vitamin D and retinoid receptor expression and signalling in primary cultures of rat osteoblastic and immortalised osteosarcoma cells10.1677/joe.0.1540063 ↗
43. Dexamethasone and retinoic acid differentially regulate growth and differentiation in an immortalised human clonal bone marrow stromal cell line with osteoblastic characteristics10.1016/S0039-128X(02)00054-5 ↗
44. Bone morphogenetic protein 2 and retinoic acid accelerate in vivo bone formation, osteoclast recruitment, and bone turnover10.1089/ten.2005.11.645 ↗
45. Refining retinoic acid stimulation for osteogenic differentiation of murine adipose-derived adult stromal cells10.1089/ten.2006.0283 ↗
46. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice10.1016/S0090-9556(25)08398-9 ↗
47. Hirota · Rinsho Ketsueki · 1997 · 38 · 7
48. Blood level studies of all-trans- and cis-retinoic acids in rats using different formulations
49. Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR
50. Preparation of poly(dl-lactide-co-glycolide) microspheres encapsulating all-trans retinoic acid10.1016/S0378-5173(03)00207-2 ↗
51. Long-term delivery of all-trans-retinoic acid using biodegradable PLLA/PEG-PLLA blended microspheres10.1016/S0378-5173(00)00676-1 ↗
52. Poly(hydroxyalkanoates) based polymeric nanoparticles for drug delivery
53. Molecular remissions induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia10.1182/blood.V94.7.2230.419k05_2230_2235 ↗
54. Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid10.1016/S0378-5173(02)00269-7 ↗
55. Gliadin nanoparticles for the controlled release of all-trans-retinoic acid10.1016/0378-5173(95)04338-1 ↗
56. Modified polyvinylalcohol for encapsulation of all-trans-retinoic acid in polymeric micelles10.1016/j.jconrel.2004.12.016 ↗
57. Polyethylenimine complexes with retinoic acid: structure, release profiles, and nanoparticles10.1021/ma000416x ↗
58. Poly(ethylene oxide)-b-poly(l-lysine) complexes with retinoic acid10.1021/ma000629m ↗
59. PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release10.1016/j.jconrel.2004.12.019 ↗
60. Polyion complex micelles composed of all-trans retinoic acid and poly(ethylene glycol)-grafted-chitosan10.1002/jps.20586 ↗
61. Mechanical properties of single electrospun drug-encapsulated nanofibres10.1088/0957-4484/17/15/045 ↗
62. Vitamin-loaded electrospun cellulose acetate nanofiber mats as transdermal and dermal therapeutic agents of vitamin A acid and vitamin E10.1016/j.ejpb.2007.03.018 ↗
63. Experimental characterization of electrospinning: the electrically forced jet and instabilities10.1016/S0032-3861(01)00540-7 ↗
64. Evaluation of medicines for human use, note for guidance on the investigation of bioavailability and bioequivalence. London; 2001.
65. Guidance for industry: dissolution testing of immediate release solid oral dosage forms. Rockville; 1997.
66. The effect of processing variables on the morphology of electrospun nanofibers and textiles10.1016/S0032-3861(00)00250-0 ↗
67. Structure and process relationship of electrospun bioabsorbable nanofiber membranes10.1016/S0032-3861(02)00275-6 ↗
68. Characterization of gelatin nanofiber prepared from gelatin-formic acid solution10.1016/j.polymer.2005.04.040 ↗
69. Beaded nanofibers formed during electrospinning10.1016/S0032-3861(99)00068-3 ↗
70. The change of bead morphology formed on electrospun polystyrene fibers10.1016/S0032-3861(03)00345-8 ↗
71. Experimental study on relationship between jet instability and formation of beaded fibers during electrospinning10.1002/pen.20304 ↗
72. Electrically driven jets10.1098/rspa.1969.0205 ↗
73. Nanometre diameter fibres of polymer, produced by electrospinning10.1088/0957-4484/7/3/009 ↗
74. DNA fibers by electrospinning10.1080/00222349708220422 ↗
75. Fiber diameter and texture of electrospun PEOT/PBT scaffolds influence human mesenchymal stem cell proliferation and morphology, and the release of incorporated compounds10.1016/j.biomaterials.2006.05.027 ↗
76. Study on morphology of electrospun poly(vinyl alcohol) mats10.1016/j.eurpolymj.2004.10.027 ↗
77. Novel bone scaffolds of electrospun polycaprolactone fibers filled with nanoparticles10.1166/jnn.2006.090 ↗
78. Crystalline morphology and polymorphic phase transitions in electrospun nylon-6 nanofibers10.1021/ma070039p ↗
79. Electrospinning: a fascinating method for the preparation of ultrathin fibers10.1002/anie.200604646 ↗
80. Micro/nanostructured polymeric systems for biomedical and pharmaceutical applications10.2217/17435889.3.3.367 ↗
81. Controlled delivery of aspirin: Effect of aspirin on polymer degradation and in vitro release from PLGA based phase sensitive systems10.1016/j.ijpharm.2008.01.053 ↗
82. Bioresorbability and biocompatibility of aliphatic polyesters10.1007/BF00701240 ↗
83. Formulation and characterization of Injectable Poly(dl-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor10.1007/s11095-007-9430-1 ↗
84. Long-term sustained release of ganciclovir from biodegradable scleral implant for the treatment of cytomegalovirus retinitis10.1016/S0168-3659(00)00267-4 ↗
85. Potential applications of PLGA film-implants in modulating in vitro drugs release10.1016/S0378-5173(02)00431-3 ↗
86. A new preparation method for protein loaded poly(dl-lactic-co-glycolic acid) microspheres and protein release mechanism study10.1016/S0168-3659(98)00050-9 ↗
87. Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide)-based electrospun nanofibrous scaffolds10.1016/j.jconrel.2004.04.009 ↗
88. Effect of retinoic acid on murine preosteoblastic MC3T3-E1 cells10.3177/jnsv.51.311 ↗
89. Retinoic acid inhibits serum-stimulated activator protein-1 via suppression of C-fos and C-jun gene expressions during the vitamin-induced differentiation of mouse osteoblastic cell line MC3T3-E1 cells
90. The effect of human osteoblasts on proliferation and neo-vessel formation of human umbilical vein endothelial cells in a long-term 3D co-culture on polyurethane scaffolds10.1016/j.biomaterials.2008.07.024 ↗